Investing

Immunome : IMNM

IMNM

Stock Data

$18.74

$0.21 (1.13%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Immunome Inc is a biotechnology firm based in Exton, Pennsylvania, focusing on creating innovative cancer treatments. With a rich portfolio that includes immunotherapies, targeted effectors, radioligand therapies, and antibody drug conjugates (ADCs), the company stands at the forefront of cancer research. Immunome is also known for its cutting-edge memory B cell hybridoma technology, which allows for the rapid screening of novel antibodies and targets, marking a significant stride in the fight against cancer since its inception in 2006.

All Immunome Articles

1 Article

Lee Jackson | Feb 12, 2026 at 8:00 AM EST

Here Are Thursday’s Top Wall Street Analyst Research Calls: BP Plc., Borg Warner, Generac, Kraft-Heinz, MercadoLibre, Pfizer, Shopify, Valvoline, and More

Pre-Market Stock Futures: Futures are trading higher after a wild Wednesday that saw the market rally hard on the open…